Stock GIKLY GRIFOLS, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Grifols, S.A. OTC Markets

Equities

GIKLY

US3984382008

Market Closed - OTC Markets
Other stock markets
 16:02:50 16/05/2024 BST 		5-day change 1st Jan Change
5.505 USD +0.82% Intraday chart for Grifols, S.A. +7.52% -36.72%
05-15 GRIFOLS : In line Q1 and on track deleveraging; worth a go Alphavalue
05-14 Grifols, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Grifols S A : on track to meet full-year guidance and reduce debt May 14 2024
PU
Grifols Q1 2024 results
AQ
Ordinary General Shareholders' Meeting
AQ
GRIFOLS, S.A. - The Board of Directors has unanimously adopted various resolutions in order to further strengthen its corporate governance system
AQ
GRIFOLS S A : The Board of Directors has unanimously adopted various resolutions in order to further strengthen its corporate governance system
PU
Grifols S A : , Haier Complete ‘Government Approval Procedures’
PU
Grifols, Haier Complete 'Government Approval Procedures'
AQ
Grifols S A : on track to close its strategic alliance with Haier in first half 2024 May 6 2024
PU
Closing of the Private Placement
AQ
Grifols Closed Private Placement Financing
AQ
Grifols S A : announces signing of private offering of EUR 1 billion senior secured notes due 2030 April 23 2024
PU
Grifols 2023 Annual Report on Form 20-F filed with the SEC
AQ
Grifols Changes Vice Secretary of the Board of Directors
AQ
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
AQ
Grifols S A : Communications - announces the commencement of the refinancing process
PU
Clarification to the CNMV Requirements
AQ
Grifols provides responses to CNMV March 21 report
AQ
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening
GL
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening
AQ
Mr. José Ignacio (Nacho) Abia, no longer holds the category of "other external" from 1 April since he has taken on executive functions as the company's Chief Executive Officer
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GRF Stock
  4. GIKLY Stock
  5. News Grifols, S.A.
  6. Press Releases